Related Experiment Video

Updated: Jun 17, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Prostate-specific antigen, prostate cancer, and disorders of hemostasis

Giuseppe Lippi1, Mario Plebani, Massimo Franchini

  • 1U.O. Diagnostica Ematochimica, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospadaliero-Universitaria di Parma, Parma, Italy. glippi@ao.pr.it

Seminars in Thrombosis and Hemostasis
|December 17, 2009
PubMed

Insights

Prostate cancer is linked to hemostatic disorders like blood clots and bleeding. Prostate-specific antigen (PSA), a cancer marker, may play a role in these coagulopathies, suggesting new research avenues.

Area of Science:

  • Oncology
  • Hematology
  • Biochemistry

Background:

  • Prostate cancer is a leading cause of cancer death in men globally.
  • Patients with prostate cancer frequently experience hemostatic disorders, including disseminated intravascular coagulation, venous thromboembolism, acute coronary syndrome, and postsurgical bleeding, contributing to mortality and morbidity.
  • Proposed mechanisms for prostate cancer-related coagulopathies involve the overexpression of tissue factor, cancer procoagulant, and platelet-activating factor, leading to the release of prothrombotic and profibrinolytic substances.

Purpose of the Study:

  • To explore the potential role of prostate-specific antigen (PSA) in the pathogenesis of hemostatic disorders associated with prostate cancer.
  • To investigate the relationship between PSA levels and markers of thrombin generation, postsurgical bleeding, coronary atherosclerosis, and myocardial infarction outcomes.

Main Methods:

  • Literature review and analysis of existing clinical and biochemical data.
  • Correlation analysis between PSA levels and various hemostatic and cardiovascular markers.

Main Results:

  • While PSA is a key biomarker for prostate cancer diagnostics, its role in hemostatic disorders remains largely speculative.
  • Emerging evidence suggests a positive correlation between PSA levels and markers of thrombin generation.
  • Observations also indicate a link between PSA levels and increased risk of postsurgical bleeding, coronary atherosclerosis, and adverse myocardial infarction outcomes.

Conclusions:

  • The pathophysiological role of PSA in prostate cancer-related coagulopathies warrants further investigation.
  • PSA may be more than a diagnostic marker, potentially influencing hemostasis and cardiovascular health in prostate cancer patients.
  • Further research is needed to elucidate the complex interplay between PSA, coagulation, and cardiovascular events in the context of prostate cancer.

More Related Videos

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...